An entirely avoidable, and deeply regrettable, controversy has been raging this week over the decision by the (formerly highly esteemed) Susan G. Komen For the Cure foundation, the world’s leading breast-cancer research advocacy group, to cut its support for Planned Parenthood, which used Komen dollars (about $600,000 annually) to pay for breast-screening exams for poor people.
Lisa Aliferis is the founding editor of KQED's State of Health blog. Since 2011, she's been writing stories and editing them for the site. Before taking up blogging, she toiled for many years producing health stories for television, including Dateline NBC and San Francisco's CBS affiliate, KPIX-TV. She also wrote up a handy guide to the Affordable Care Act, especially for Californians. You can follow her on Twitter: @laliferisView all posts by Lisa Aliferis →